Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
David E. Neal(University of Cambridge), Andrew Doble, Freddie C. Hamdy(University of Oxford), Roger Kockelbergh(University Hospitals of Leicester NHS Trust), Eleanor Walsh(University of Bristol), Grace Young(University of Bristol), Vincent J. Gnanapragasam(Addenbrooke's Hospital), John Staffurth(Velindre NHS Trust), Derek J. Rosario(Royal Hallamshire Hospital), James W.F. Catto(University of Sheffield), Malcolm D. Mason(Royal Marsden Hospital), Peter Holding(University of Oxford), Edward Rowe(Southmead Hospital), Prasad Bollina(Western General Hospital), Edgar Páez(Freeman Hospital), Jenny Donovan(At Bristol), T. J. Peters(University Of Bristol Dental Hospital), Alan Paul(Queen Elizabeth Hospital Birmingham), Richard J. Bryant(University of Oxford), Emma L. Turner(University of Bristol), Alan Doherty(Queen Elizabeth Hospital Birmingham), Owen Hughes(Cardiff and Vale University Health Board), Richard M. Martin(Drug Safety Research Unit), Philip Powell(Freeman Hospital), Jon Oxley(North Bristol NHS Trust), J. Athene Lane(University of Bristol), Susan Dutton(Oxford Centre for Diabetes, Endocrinology and Metabolism), Howard Kynaston(Cardiff University), Chris Metcalfe(University of Bristol), Stephen M. Prescott(MACOM (United States)), Michael Davis(University of Bristol), David Gillatt(University of Bristol), Doug Altman(University of Oxford)
Cited by 150
Related Papers
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
|BMJ|2010|9k
International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project
|The Lancet|2014|2.3k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k